Skip to content
Disclosery

EXANE DERIVATIVES: SRE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SRE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,431 SRE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,431 shares
    Change vs previous 13F -3,661 shares

    0.12% of the 13F portfolio, value $215,010.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 5,092 shares
    Change vs previous 13F -1,221 shares

    0.24% of the 13F portfolio, value $856,073.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 6,313 shares
    Change vs previous 13F +3,715 shares

    0.2% of the 13F portfolio, value $835,111.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,598 shares
    Change vs previous 13F +405 shares

    0.08% of the 13F portfolio, value $328,658.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,193 shares
    Change vs previous 13F +1,784 shares

    0.07% of the 13F portfolio, value $289,744.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 409 shares
    Change vs previous 13F +62 shares

    0.02% of the 13F portfolio, value $54,227.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 347 shares
    Change vs previous 13F +146 shares

    0.01% of the 13F portfolio, value $44,213.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 201 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $23,791.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).